118 related articles for article (PubMed ID: 2118015)
1. CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHA.
Katagiri K; Nakano T; Sugawara Y; Ichikawa Y; Yoshida T
Clin Immunol Immunopathol; 1990 Sep; 56(3):384-92. PubMed ID: 2118015
[TBL] [Abstract][Full Text] [Related]
2. CCA [N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt], a newly developed immunomodulating drug, suppresses T-cell activation by acting on macrophages.
Takeuchi T; Koide J; Hosono O; Takano M; Abe T
Inflammation; 1989 Apr; 13(2):125-35. PubMed ID: 2527202
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological study of CCA (Lobenzarit disodium), an anti-arthritis agent--I. Abrogation of IL 1 secretion by LPS-stimulated human monocytes and induction of gamma-interferon production with CCA.
Fujimoto M; Sugawara I; Kimoto M; Ishizaka S; Tsujii T
Int J Immunopharmacol; 1986; 8(3):323-8. PubMed ID: 3089953
[TBL] [Abstract][Full Text] [Related]
4. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
5. Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug.
Hirohata S; Shinohara S; Inoue T; Miyamoto T; Lipsky PE
Arthritis Rheum; 1992 Feb; 35(2):168-75. PubMed ID: 1734906
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
[TBL] [Abstract][Full Text] [Related]
7. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
8. Effect of schistosome-derived inhibitory factor on the cell cycle of T lymphocytes.
Mazingue C; Walker C; Domzig W; Capron A; De Weck A; Stadler BM
Int Arch Allergy Appl Immunol; 1987; 83(1):12-8. PubMed ID: 3106241
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation.
Reed JC; Nowell PC; Hoover RG
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4221-4. PubMed ID: 3873657
[TBL] [Abstract][Full Text] [Related]
10. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression.
Yang SX; Xie SS; Gao HL; Ma DL; Long ZZ
Int J Immunopharmacol; 1994 Nov; 16(11):895-904. PubMed ID: 7868294
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
12. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
Rigby WF; Noelle RJ; Krause K; Fanger MW
J Immunol; 1985 Oct; 135(4):2279-86. PubMed ID: 2993410
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells.
Kanda N; Watanabe S
J Immunol; 2001 Jan; 166(1):72-80. PubMed ID: 11123278
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding.
Rigby WF; Hamilton BJ; Waugh MG
Cell Immunol; 1990 Feb; 125(2):396-414. PubMed ID: 2105168
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
17. Alleviation of depressed immunity caused by restraint-stress, by the immunomodulator, lobenzarit disodium (disodium 4-chloro-2,2'-iminodibenzoate).
Komori T; Nakano T; Ohsugi Y
Int J Immunopharmacol; 1987; 9(4):433-41. PubMed ID: 3623769
[TBL] [Abstract][Full Text] [Related]
18. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle.
Mattern T; Ansorge S; Flad HD; Ulmer AJ
Immunobiology; 1993 Jun; 188(1-2):36-50. PubMed ID: 8104880
[TBL] [Abstract][Full Text] [Related]
20. Theophylline and the immune response: in vitro and in vivo effects.
Scordamaglia A; Ciprandi G; Ruffoni S; Caria M; Paolieri F; Venuti D; Canonica GW
Clin Immunol Immunopathol; 1988 Aug; 48(2):238-46. PubMed ID: 3134151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
